Flexible Solutions International (FSI)
(Delayed Data from AMEX)
$2.00 USD
-0.02 (-0.99%)
Updated Aug 2, 2024 03:57 PM ET
After-Market: $2.01 +0.01 (0.50%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
FSI 2.00 -0.02(-0.99%)
Will FSI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for FSI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FSI
Orion (OEC) Q2 Earnings and Revenues Lag Estimates
Flexible Solutions (FSI) Q1 Earnings and Sales Lag Estimates
FSI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Innospec (IOSP) Q1 Earnings Beat Estimates
Nutrien (NTR) Beats Q1 Earnings and Revenue Estimates
AdvanSix (ASIX) Reports Q1 Loss, Misses Revenue Estimates
Other News for FSI
FSI ANNOUNCES SECOND QUARTER 2024 REVENUE
Flexible Solutions reports Q1 EPS 4c vs 7c last year
Oil price bounce drives global commodity open interest value rebound – JPM
FSI ANNOUNCES CAPEX EXPENDITURE TO ACQUIRE A VIAL FILLING LINE FOR INJECTABLE DRUGS SUCH AS GLP1 FOR WEIGHT LOSS
Flexible Solutions announces acquisition of production line for vial filling